Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multivariate tests for multiple endpoints in clinical trials

D Follmann1

  • 1Biostatistics Research Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA.

Statistics in Medicine
|June 15, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.

Blood·2001
Same author

Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial.

Circulation·2001
Same author

Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators.

Journal of the American College of Cardiology·2001
Same author

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

European heart journal·2000
Same author

Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators.

Circulation·2000
Same author

Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

Journal of the American College of Cardiology·1999
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

This study compares statistical methods for analyzing multiple clinical trial endpoints. A novel risk score test is proposed, offering a clinically relevant approach for evaluating treatment efficacy across diverse outcomes.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Statistical Analysis

Background:

  • Clinical trials often require multiple endpoints to fully capture treatment efficacy.
  • A single definitive endpoint may not adequately represent a treatment's multifaceted effects.
  • Statistical methods are needed to synthesize results from multiple endpoints into a single p-value.

Purpose of the Study:

  • To review and compare existing statistical procedures for analyzing multiple endpoints in clinical trials.
  • To introduce and evaluate a novel risk score test for assessing treatment efficacy.
  • To identify optimal statistical approaches based on clinical relevance and non-standard alternatives.

Main Methods:

  • Review of established statistical tests: Hotelling's T2, approximate likelihood ratio test (Tang et al.), weighted O'Brien's test, maximum of several test statistics, and average of maximum endpoints (Wittes).

Related Experiment Videos

  • Development and proposal of a risk score test with a constant risk contour rejection boundary.
  • Comparative analysis using calculations and simulation studies.

    • Main Results:

    • The study evaluates the performance of various statistical tests under different conditions.
    • The proposed risk score test is compared against existing methods, focusing on non-standard alternatives.
    • Simulation results highlight scenarios where certain tests may lack clinical relevance.

    Conclusions:

    • Multiple statistical approaches exist for analyzing multiple endpoints in clinical trials.
    • The proposed risk score test offers a potentially more clinically relevant method for evaluating treatment efficacy.
    • Careful selection of statistical methods is crucial for accurate interpretation of clinical trial results.